Bavarian Nordic - The sky is the limit
eröffnet am 04.06.11 19:10:57 von
neuester Beitrag 03.06.24 14:43:40 von
neuester Beitrag 03.06.24 14:43:40 von
Beiträge: 2.182
ID: 1.166.681
ID: 1.166.681
Aufrufe heute: 4
Gesamt: 103.494
Gesamt: 103.494
Aktive User: 0
ISIN: DK0015998017 · WKN: 917165 · Symbol: BV3
23,995
EUR
-1,54 %
-0,375 EUR
Letzter Kurs 12:27:47 L&S Exchange
Neuigkeiten
TitelBeiträge |
---|
31.05.24 · globenewswire |
30.05.24 · globenewswire |
22.05.24 · globenewswire |
21.05.24 · globenewswire |
Werte aus der Branche Biotechnologie
Wertpapier | Kurs | Perf. % |
---|---|---|
70,10 | +59,32 | |
1,8500 | +47,99 | |
6,9600 | +24,29 | |
1,2600 | +21,15 | |
0,6700 | +17,42 |
Wertpapier | Kurs | Perf. % |
---|---|---|
2,7600 | -26,20 | |
1,2525 | -26,32 | |
0,5541 | -40,93 | |
0,9500 | -43,11 | |
4,7000 | -44,71 |
Beitrag zu dieser Diskussion schreiben
Queensland records 10 cases of mpox, formerly known as 'monkeypox', in state's biggest cluster in history
https://www.msn.com/en-au/health/other/queensland-records-10… Kongo leidet unter größtes Trumpf-Ausbruch aller Zeiten, der sich bald auf die USA ausbreiten könnte.
https://www.dailymail.co.uk/health/article-13426901/new-infe… Mutierte Mpox-Viren lassen Fallzahlen steigen -Impfstoffe von Bavarian Nordic
Derzeit existieren drei Impfstoffe: OrthopoxVac, LC16 und Modified Vaccinia Ankara – Bavarian Nordic (MVA-BN).https://www.deutsche-apotheker-zeitung.de/news/artikel/2024/…
!
Dieser Beitrag wurde von CloudMOD moderiert. Grund: themenfremder Inhaltmpox-Fall in Südafrika
https://www.msn.com/en-za/health/other/health-minister-alert…
Antwort auf Beitrag Nr.: 75.765.237 von Beutelschneider2020 am 10.05.24 17:40:49
Bavarian Nordic verdient Geld und kauft auf niedrigem Niveau weiter eigene Aktien zurück.
Bavarian Nordic kauft weiter eigene Aktien zurück
https://www.wallstreet-online.de/nachricht/18071400-bavarian…Bavarian Nordic verdient Geld und kauft auf niedrigem Niveau weiter eigene Aktien zurück.
Antwort auf Beitrag Nr.: 75.698.442 von Flymetothemoon am 28.04.24 20:29:50
So langsam könnte man wirklich mal wieder ein bischen investieren. Beim Ausbruch 2022 liess sich hier schnell eine Menge Geld verdienen.
Geht es etwa wieder los?
Zitat von Flymetothemoon: https://www.kasu.org/health-science/2024-04-26/drc-is-seeing-its-worst-mpox-outbreak-but-has-no-vaccines-or-treatments-yet-why
So langsam könnte man wirklich mal wieder ein bischen investieren. Beim Ausbruch 2022 liess sich hier schnell eine Menge Geld verdienen.
BAVARIAN NORDIC RECEIVES 65M EUR CONTRACT TO SUPPLY SMALLPOX VACCINES FOR EU STRATEGIC RESERVE
April 29, 2024
Bavarian Nordic A/S (OMX: BAVA) today announced the award of a contract valued at EUR 65 million to supply its MVA-BN® smallpox vaccine to the strategic reserve within the European Union (EU) in 2025. This third, and larger order follows two previous orders, received in 2023 and delivered in 2024, for smallpox vaccines to rescEU stockpiles across Europe and will help to expand the EU’s capability to respond to future biological threats and emergencies by enabling rapid deployment of medical countermeasures to its member states.
https://www.bavarian-nordic.com/media/media/news.aspx?news=6…
April 29, 2024
Bavarian Nordic A/S (OMX: BAVA) today announced the award of a contract valued at EUR 65 million to supply its MVA-BN® smallpox vaccine to the strategic reserve within the European Union (EU) in 2025. This third, and larger order follows two previous orders, received in 2023 and delivered in 2024, for smallpox vaccines to rescEU stockpiles across Europe and will help to expand the EU’s capability to respond to future biological threats and emergencies by enabling rapid deployment of medical countermeasures to its member states.
https://www.bavarian-nordic.com/media/media/news.aspx?news=6…
Antwort auf Beitrag Nr.: 75.702.255 von Nokery am 29.04.24 15:42:27The CHIKV VLP vaccine candidate received Breakthrough Therapy designation and Fast Track designation from the FDA in October 2020 and April 2018, respectively, and PRIME designation from the EMA in September 2019. These designations are designed to facilitate the development or expedite review of medicines that either target an unmet medical need or may demonstrate substantial improvement over available therapy. In February 2024, the Committee for Medicinal Products for Human Use (CHMP) under EMA granted accelerated assessment for the MAA for the CHIKV VLP vaccine candidate, which Bavarian Nordic plans to submit by mid-2024.
BAVARIAN NORDIC INITIATES ROLLING SUBMISSION OF BIOLOGICS LICENSE APPLICATION WITH FDA FOR ITS CHIKUNGUNYA VACCINE CANDIDATE
COPENHAGEN, Denmark, April 29, 2024
– Bavarian Nordic A/S (OMX: BAVA) today announced that it has initiated the rolling submission process with the U.S. Food and Drug Administration (FDA) for a Biologics License Application (BLA) for the licensure of its CHIKV VLP vaccine candidate for immunization against chikungunya virus infection in individuals 12 years of age and older.
Bavarian Nordic will submit additional data over the coming months, aiming to complete the BLA submission before the end of the first half of 2024 to support a potential FDA approval of the vaccine in the first half of 2025.
https://www.bavarian-nordic.com/media/media/news.aspx?news=6…
COPENHAGEN, Denmark, April 29, 2024
– Bavarian Nordic A/S (OMX: BAVA) today announced that it has initiated the rolling submission process with the U.S. Food and Drug Administration (FDA) for a Biologics License Application (BLA) for the licensure of its CHIKV VLP vaccine candidate for immunization against chikungunya virus infection in individuals 12 years of age and older.
Bavarian Nordic will submit additional data over the coming months, aiming to complete the BLA submission before the end of the first half of 2024 to support a potential FDA approval of the vaccine in the first half of 2025.
https://www.bavarian-nordic.com/media/media/news.aspx?news=6…
31.05.24 · globenewswire · Bavarian Nordic |
30.05.24 · globenewswire · Bavarian Nordic |
22.05.24 · globenewswire · Bavarian Nordic |
21.05.24 · globenewswire · Bavarian Nordic |
21.05.24 · globenewswire · Bavarian Nordic |
08.05.24 · globenewswire · Bavarian Nordic |
08.05.24 · globenewswire · Bavarian Nordic |
07.05.24 · globenewswire · Bavarian Nordic |
29.04.24 · globenewswire · Bavarian Nordic |
29.04.24 · globenewswire · Bavarian Nordic |